Skip to content
Home/Companies/MedTech/Qrem
Qrem

Qrem

MedTech·Spain·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Qrem?

Qrem is currently owned by Inveready Asset Management through Inveready Biotech III (2020 vintage), since 2020.

Hand-verified · updated 2026-08-10

Inveready Asset Management
Investor
Inveready Asset Management
Inveready Biotech III · 2020 · Life Sciences VC

Key facts

HQSpain
SectorMedTech
StatusActive
Websiteqrem-regenerative.com

More from Inveready Biotech III

Other portfolio companies in the same fund.

Iteria
Active
BiotechSpain· 2026
Pharmacelera
Active
BiotechSpain· 2026
Nanoligent
Active
BiotechSpain· 2025
Disrupt
Disrupt
Active
HealthTechSpain· 2024
Geniova
Geniova
Active
MedTechSpain· 2024
Lev2050
Active
BiotechSpain· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Qrem

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Qrem.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue